Piramal Enterprises has received approval to raise up to Rs 50 crore along with an option to retain over subscription of up to Rs 325 crore, aggregating up to Rs 375 crore through issuance of Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (Debentures) on private placement basis.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.